Gloved hand dropping liquid from a pipette on a microscope slide
Gloved hand dropping liquid from a pipette on a microscope slide

ASCO 2022

OVERVIEW

03 - 07

Jun 2022

ASCO 2022

Chicago, IL
Congress website

Annual meeting featuring presentations on the latest research in cancer care.

TAFASITAMAB PRESENTATIONS

  • Poster

    frontMIND: A Phase III, randomized, double-blind study of tafasitamab + lenalidomide + R-CHOP vs R-CHOP alone for newly diagnosed high-intermediate and high-risk diffuse large B-cell lymphoma

  • Poster

    Subgroup analysis in RE-MIND2, an observational, retrospective cohort study of tafasitamab plus lenalidomide versus systemic therapies in patients with relapsed/refractory diffuse large B-cell lymphoma

OTHER CONGRESSES

EHA 2022

European-based organization and congress promoting excellence in hematology.

09/06 - 12/06 Vienna, Austria
LEARN MORE

SOHO 2022

Annual meeting of global society of clinicians and scientists specializing in hematology.

28/09 - 01/10 Houston, TX
LEARN MORE

EORTC-NCI-AACR 2022

Symposium and programming on drug development and translational research.

26/10 - 28/10 Barcelona, Spain
LEARN MORE

MorphoSys is providing the data presented at medical congresses as part of scientific exchange. The scientific information may include data/information on investigational use(s) of compounds/drugs of which the efficacy and safety have not yet been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of MorphoSys’ products. Copies of congress presentations may not be reproduced without written permission from the congress and the authors.